Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection
© The Author(s) 2023. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com..
We assessed serum neutralization of Omicron BA.5 in children following SARS-CoV-2 infection during the Delta or Omicron BA.1/BA.2 variant period. Convalescent BA.5 titers were higher following infections during the Omicron BA.1/BA.2 vs Delta variant period, and in vaccinated vs unvaccinated children. Titers against BA.5 did not differ by age group.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
|---|---|
| Enthalten in: |
Journal of the Pediatric Infectious Diseases Society - 13(2024), 1 vom: 29. Jan., Seite 100-104 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Belongia, Edward A [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies, Viral |
|---|
| Anmerkungen: |
Date Completed 30.01.2024 Date Revised 30.01.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/jpids/piad109 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM366327879 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM366327879 | ||
| 003 | DE-627 | ||
| 005 | 20240130232136.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231227s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/jpids/piad109 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1275.xml |
| 035 | |a (DE-627)NLM366327879 | ||
| 035 | |a (NLM)38142128 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Belongia, Edward A |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Neutralizing Immunity Against Antigenically Advanced Omicron BA.5 in Children After SARS-CoV-2 Infection |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.01.2024 | ||
| 500 | |a Date Revised 30.01.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2023. Published by Oxford University Press on behalf of The Journal of the Pediatric Infectious Diseases Society. All rights reserved. For permissions, please e-mail: journals.permissionsoup.com. | ||
| 520 | |a We assessed serum neutralization of Omicron BA.5 in children following SARS-CoV-2 infection during the Delta or Omicron BA.1/BA.2 variant period. Convalescent BA.5 titers were higher following infections during the Omicron BA.1/BA.2 vs Delta variant period, and in vaccinated vs unvaccinated children. Titers against BA.5 did not differ by age group | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Omicron | |
| 650 | 4 | |a SARS-CoV-2 infection | |
| 650 | 4 | |a cross-neutralization | |
| 650 | 4 | |a neutralizing antibodies | |
| 650 | 7 | |a Antibodies, Viral |2 NLM | |
| 700 | 1 | |a Petrie, Joshua G |e verfasserin |4 aut | |
| 700 | 1 | |a Feldstein, Leora R |e verfasserin |4 aut | |
| 700 | 1 | |a Guan, Lizheng |e verfasserin |4 aut | |
| 700 | 1 | |a Halfmann, Peter J |e verfasserin |4 aut | |
| 700 | 1 | |a King, Jennifer P |e verfasserin |4 aut | |
| 700 | 1 | |a Neumann, Gabriele |e verfasserin |4 aut | |
| 700 | 1 | |a Pattinson, David |e verfasserin |4 aut | |
| 700 | 1 | |a Rolfes, Melissa A |e verfasserin |4 aut | |
| 700 | 1 | |a McLean, Huong Q |e verfasserin |4 aut | |
| 700 | 1 | |a Kawaoka, Yoshihiro |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of the Pediatric Infectious Diseases Society |d 2012 |g 13(2024), 1 vom: 29. Jan., Seite 100-104 |w (DE-627)NLM227436326 |x 2048-7207 |7 nnns |
| 773 | 1 | 8 | |g volume:13 |g year:2024 |g number:1 |g day:29 |g month:01 |g pages:100-104 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/jpids/piad109 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 13 |j 2024 |e 1 |b 29 |c 01 |h 100-104 | ||